D
Arcellx, Inc. ACLX
$63.71 -$0.26-0.41% NASDAQ
Recommendation
Prev Close
$63.71
Volume
295,950
Avg Vol (90D)
663,541
Market Cap
$3.50B
Dividend & Yield
--
52-Week Range
$47.88 - $107.37
P/E (TTM)
--
EPS (TTM)
-$1.99
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
William Blair Sticks to Its Buy Rating for Arcellx Inc (ACLX)
4/25/2025 - TipRanks Financial Blog
8,303 Shares in Arcellx, Inc. (NASDAQ:ACLX) Bought by Guggenheim Capital LLC
4/25/2025 - Ticker Report
Barclays PLC Increases Position in Arcellx, Inc. (NASDAQ:ACLX)
4/25/2025 - Ticker Report
Arcellx, Inc. (ACLX): Among Takeover Rumors Hedge Funds Are Buying
4/24/2025 - Insider Monkey
Arcellx (ACLX, $60.93) entered Uptrend as Momentum indicator ascends above 0 level on Apr 21, 2025
4/22/2025 - Tickeron - Stocks
252,878 Shares in Arcellx, Inc. (NASDAQ:ACLX) Purchased by Capital World Investors
4/22/2025 - Ticker Report
10,659 Shares in Arcellx, Inc. (NASDAQ:ACLX) Purchased by Walleye Capital LLC
4/22/2025 - Ticker Report
6,720,803 Shares in Arcellx, Inc. (NASDAQ:ACLX) Bought by Gilead Sciences Inc.
4/20/2025 - MarketBeat
Arcellx, Inc. (NASDAQ:ACLX) is Affinity Asset Advisors LLC's 3rd Largest Position
4/17/2025 - MarketBeat
Arcellx (ACLX, $61.43) entered Uptrend as Momentum indicator ascends above 0 level on Apr 15, 2025
4/16/2025 - Tickeron - Stocks
Trexquant Investment LP Purchases Shares of 7,237 Arcellx, Inc. (NASDAQ:ACLX)
4/15/2025 - MarketBeat
JPMorgan Chase & Co. Sells 25,667 Shares of Arcellx, Inc. (NASDAQ:ACLX)
4/14/2025 - MarketBeat
Russell Investments Group Ltd. Has $20.66 Million Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX)
4/12/2025 - MarketBeat
Arcellx (ACLX): Among Billionaire Stanley Druckenmiller's Top Stock Picks with Huge Upside Potential
4/11/2025 - Insider Monkey
Arcellx (NASDAQ:ACLX) Shares Down 6.8% on Insider Selling
4/11/2025 - MarketBeat
Billionaire Stanley Druckenmiller's Top 10 Stocks Picks with Huge Upside Potential
4/11/2025 - Insider Monkey
Kavita Patel Sells 1,500 Shares of Arcellx, Inc. (NASDAQ:ACLX) Stock
4/11/2025 - MarketBeat
We Think Arcellx (NASDAQ:ACLX) Can Easily Afford To Drive Business Growth
4/9/2025 - Simply Wall St
Landscape Capital Management L.L.C. Makes New Investment in Arcellx, Inc. (NASDAQ:ACLX)
4/9/2025 - Ticker Report
Interesting ACLX Put And Call Options For December 19th
4/7/2025 - Stock Options Channel
Bryce Point Capital LLC Invests $573,000 in Arcellx, Inc. (NASDAQ:ACLX)
4/5/2025 - MarketBeat
Arcellx (NASDAQ:ACLX) Trading Up 4.6% - Still a Buy?
4/4/2025 - MarketBeat
Arcellx (NASDAQ:ACLX) Shares Down 7.7% - Time to Sell?
4/1/2025 - MarketBeat
Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by NEOS Investment Management LLC
4/1/2025 - MarketBeat
Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by NEOS Investment Management LLC
3/31/2025 - Ticker Report
Income Statement
Total Revenue (TTM)
$107.94M
EBITDA (TTM)
-$132.38M
EBIT (TTM)
-$137.57M
Net Income (TTM)
-$107.35M
Balance Sheet
Total Assets (Q)
$711.33M
Total Debt (Q)
$54.08M
Total Liabilities (Q)
$256.54M
Book Value Per Share (Q)
$8.38
Cash Flow
Cash from Operations (TTM)
-$83.47M
Cash from Investing (TTM)
-$183.05M
Cash from Financing (TTM)
-$24.09M
Net Change in Cash (TTM)
-$290.60M
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.48
7-Day Total Return
4.98%
30-Day Total Return
-11.12%
60-Day Total Return
-5.73%
90-Day Total Return
-23.97%
Year to Date Total Return
-19.10%
1-Year Total Return
22.71%
2-Year Total Return
43.20%
3-Year Total Return
472.42%
5-Year Total Return
--
52-week Low
May 10, 2024 - $47.88
52-week High
Nov 12, 2024 - $107.37
Valuation
Market Cap
$3.50B - Mid Cap
Enterprise Value
$2.93B
Price/Sales (TTM)
31.97
Price/Book (Q)
7.61
Dividends and Shares
Shares Outstanding
54.16M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.arcellx.com
Phone Number
240 327 0630
Address
800 Bridge Parkway
Redwood City, CA 94065
Country
United States
Year Founded
2014
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company’s lead... more
NASDAQ 04/25/2025 4:00PM Eastern Quotes delayed